Lucid Net Income Per Share from 2010 to 2026
| LUCD Stock | USD 1.34 -0.04 -2.90% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -1.04 | Current Value -1.09 | Quarterly Volatility 0.54076147 |
Macro event markers
Analyzing Lucid Diagnostics's Net Income Per Share over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Per Share has evolved provides context for assessing Lucid Diagnostics's current valuation and future prospects.
Latest Lucid Diagnostics' Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of Lucid Diagnostics over the last few years. It is Lucid Diagnostics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lucid Diagnostics' overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Lucid Net Income Per Share Regression Statistics
| Arithmetic Mean | -0.43 | |
| Coefficient Of Variation | -126.95 | |
| Mean Deviation | 0.48 | |
| Median | -0.03 | |
| Standard Deviation | 0.54 | |
| Sample Variance | 0.29 | |
| Range | 1.5224 | |
| R-Value | -0.82 | |
| Mean Square Error | 0.10 | |
| R-Squared | 0.67 | |
| Significance | 0.000061 | |
| Slope | -0.09 | |
| Total Sum of Squares | 4.68 |
Lucid Net Income Per Share History
Methodology, Assumptions & Data Sources
Lucid Diagnostics's Net Income Per Share reference series captures how this indicator has evolved through different market cycles. Mean-reversion tendencies in this metric may inform forward estimates.
For Lucid Diagnostics, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Intraday timing differences may exist. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.